| Literature DB >> 30966341 |
Raquel Viveiros1, Sílvia Rebocho2, Teresa Casimiro3.
Abstract
Molecular imprinting is a powerful technology to create artificial receptors within polymeric matrices. Although it was reported for the first time by Polyakov, eighty-four years ago, it remains, nowadays, a very challenging research area. Molecularly imprinted polymers (MIPs) have been successfully used in several applications where selective binding is a requirement, such as immunoassays, affinity separation, sensors, and catalysis. Conventional methods used on MIP production still use large amounts of organic solvents which, allied with stricter legislation on the use and release of chemicals to the environment and the presence of impurities on final materials, will boost, in our opinion, the use of new cleaner synthetic strategies, in particular, with the application of the principles of green chemistry and engineering. Supercritical carbon dioxide, microwave, ionic liquids, and ultrasound technology are some of the green strategies which have already been applied in MIP production. These strategies can improve MIP properties, such as controlled morphology, homogeneity of the binding sites, and the absence of organic solvents. This review intends to give examples reported in literature on green approaches to MIP development, from nano- to micron-scale applications.Entities:
Keywords: deep eutectic solvents (DESs); ionic liquids; microwave synthesis; molecular imprinting; supercritical carbon dioxide; ultrasound-assisted
Year: 2018 PMID: 30966341 PMCID: PMC6415187 DOI: 10.3390/polym10030306
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Molecularly imprinted polymer (MIP) synthesis in supercritical carbon dioxide (scCO2).
| Template | Strategy | Monomer | Crosslinker | Particle Size Diameter | Year | Ref. |
|---|---|---|---|---|---|---|
| Salicylic acid and acetylsalicylic acid | Non-covalent | DEGDMA | - | 1.7 μm | 2006 | [ |
| Propranolol | Non-covalent | MAA | DVB | 100 nm | 2006 | [ |
| Boc- | Non-covalent | NIPAAm | EGDMA | micron-sized | 2010 | [ |
| Flufenamic acid | Non-covalent | MAA | EGDMA | micron-sized | 2011 | [ |
| Ibuprofen | Non-covalent | DMAEMA | EGDMA | ~1 μm | 2011 | [ |
| Bisphenol A | Non-covalent | MAA, | EGDMA | micron-sized | 2012, 2018 | [ |
| Bisphenol A | Semi-covalent | BPADM | EGDMA | micron-sized | 2012 | [ |
| Aspirin and Acetaminophen | Non-covalent | MAA | EGDMA | 250–300 nm | 2013 | [ |
| Bisphenol A and | Non-covalent | MAA | EGDMA | 300 nm | 2013 | [ |
| Carbamazepine | Non-covalent | MAA | EGDMA | 200 nm | 2013 | [ |
| Labdanolic acid | Non-covalent | DMAEMA | EGDMA | micron-sized | 2014 | [ |
| DBTSO2 | Non-covalent | MAA | EGDMA | micron-sized | 2014 | [ |
| Gallic acid | Non-covalent | MAA | EGDMA | 150–200 nm | 2016 | [ |
| Acetamide | Non-covalent | MAA and MAM, | EGDMA | 3.4–5.3 μm | 2017 | [ |
Figure 1Scheme for the production of MIP-layered silica beads: (a) 3-(Trimethoxysilyl) propyl methacrylate (MPS)-functionalization in scCO2; (b) plasma functionalization of silica beads, in which R are the radicals produced; (c) MIP-layered core-shell beads produced in scCO2. Reproduced from reference [52] with permission from Elsevier.
Figure 2Protocol for the synthesis of MIPs for l-phenylalanine using 1-butyl-3-methylimidazolium α-aminohydrocinnamic acid salt [BMIM][Phe] as template. Reproduced from reference [67] with permission from John Wiley and Sons.